Diet drug concept stocks were active at the beginning of trading, and Jinkai Biosciences rose by more than 10%

2025-04-18 09:27:29

Weight loss drug concept was active at the beginning of the session, with Jinkai Biosciences rising more than 10%, followed by Haofan Bio, Huadong Medicine, Hanyu Pharmaceutical, Baihua Pharmaceutical, Yipinhong, Changshan Pharmaceutical, etc. On the news front, Eli Lilly's oral weight loss drug Orforglipron had impressive Phase III clinical data, and its stock price rose by more than 14%.

weight loss drug Lilly

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Nvidia (NVDA.O): Blackwell chips have begun production at TSMC's chip factory in Phoenix, Arizona.
                            2025-04-14

                                    Li Lecheng, Secretary of the Party Leadership Group of the Ministry of Industry and Information Technology, meets with Sultan, Minister of Industry and Advanced Technology of the United Arab Emirates
                            2025-04-18

                                    BOE A: Net profit is expected to increase by 63% to 68% year-on-year in the first quarter of 2025
                            2025-04-15

                                    Faraday Future (FFIE.O) announced that it firmly opposes reverse stock splits and is committed to maintaining its listing status on Nasdaq. CEO Mark will meet with White House decision makers.
                            2025-04-17

                                    Kugou Music Viper Sound Quality cooperates with MediaTek chips to realize new device-side AI data saving technology
                            2025-04-11